ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms bioRxiv
The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia BLOOD ADV
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary Future Oncol
FDG-PET/CT-guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma CANCER MED-US
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma Haematologica
Global Impairment of Immediate-Early Genes Expression in Rett Syndrome Models and Patients Linked to Myelination Defects INT J MOL SCI